NCT04300855View on ClinicalTrials.gov

Clinical Trial of Green Tea Catechins in Men on Active Surveillance

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

August 21, 2020

Primary Completion Date

February 27, 2027

Study Completion Date

February 27, 2027

Conditions
Prostate CancerProstate Adenocarcinoma
Interventions
DRUG

Sunphenon

The study agent will be administered in divided doses with food, three capsules twice a day (405 mg) for 24 months

DRUG

Placebo

Matching placebo

Trial Locations (2)

33612

Moffitt Cancer Center, Tampa

66205

University of Kansas Cancer Center, Westwood

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER